The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Severe Influenza with Oseltamivir Resistance

Severe or critical influenza disease (pneumonia, ARDS, multi-organ failure) caused by oseltamivir-resistant strains carrying H275Y mutation in neuraminidase (NA) gene of A(H1N1)pdm09 or pandemic strains, requiring switch to alternative antivirals (zanamivir, peramivir, baloxavir), prolonged ICU support, and consideration of combination therapy in immunocompromised hosts with persistent viral shedding.

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Internal Medicine department. Book Appointment →

What is Severe Influenza with Oseltamivir Resistance?

Influenza neuraminidase inhibitors (NAIs) - oseltamivir, zanamivir, peramivir - bind the active site of neuraminidase enzyme preventing release of progeny virions from infected cells. Oseltamivir resistance most commonly arises through H275Y substitution (histidine to tyrosine at position 275) in N1 neuraminidase, causing 200-1000 fold reduction in oseltamivir susceptibility while only modest changes for zanamivir. The H275Y mutation confers cross-resistance to peramivir but preserves susceptibility to zanamivir and baloxavir (which targets viral PA endonuclease, not NA).

Background prevalence of oseltamivir resistance is <1% in circulating seasonal A(H1N1)pdm09 strains globally, but resistance emerges during treatment in 1-2% of immunocompetent and 5-30% of immunocompromised patients (HCT, SOT, hematologic malignancy) due to prolonged viral replication and selective antiviral pressure. Pre-2009, the seasonal A(H1N1) virus had near-universal H275Y resistance from 2007-2009 winter season, and seasonal H3N2 has very rare oseltamivir resistance.

Clinical presentation of severe influenza includes high fever, severe myalgia, viral pneumonia with bilateral infiltrates, ARDS, secondary bacterial pneumonia (especially S. aureus, S. pneumoniae), myocarditis, encephalopathy, rhabdomyolysis, and multi-organ failure. Risk factors for severe disease include pregnancy, age >65, age <2 years, chronic lung/heart/kidney/liver disease, immunosuppression, obesity (BMI >40), and pregnancy. Diagnosis requires RT-PCR for influenza A/B with H275Y mutation testing on respiratory specimens for resistance characterization.

Symptoms

High fever, chills, severe myalgia
Severe dyspnea and hypoxemia (viral pneumonia, ARDS)
Productive cough, sometimes hemoptysis
Cardiovascular collapse, shock
Encephalopathy, altered mental status
Acute kidney injury (AKI)
Persistent viral shedding despite oseltamivir (resistance suspicion)

Risk Factors

Immunocompromised state (HCT, SOT, hematologic malignancy)
Pregnancy and postpartum period
Age >65 or <2 years
Chronic lung disease (COPD, asthma, ILD)
Heart, kidney, liver disease
Obesity (BMI >40)
Prolonged viral shedding despite oseltamivir treatment

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Severe influenza with respiratory failure
  • Persistent viral shedding despite oseltamivir 75 mg BID
  • Immunocompromised patient with influenza pneumonia
  • ARDS or shock in influenza patient
  • Suspected oseltamivir resistance (resistance testing)
  • Pregnancy with severe influenza
  • Multi-organ failure in influenza

Treatment Methods

01
Switch to IV zanamivir or inhaled zanamivir (preserved activity vs H275Y)
02
IV peramivir (most strains susceptible despite H275Y)
03
Oral baloxavir marboxil (PA endonuclease inhibitor, different resistance pathway)
04
Combination therapy: oseltamivir + amantadine (rarely used, debated)
05
Mechanical ventilation, prone positioning for ARDS
06
ECMO in refractory respiratory failure
07
Treat secondary bacterial pneumonia (S. aureus, S. pneumoniae)

Which Department to Visit?

You can visit our Enfeksiyon Hastalıkları department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Enfeksiyon Hastalıkları Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Flu (Influenza)

Enfeksiyon Hastalıkları

Influenza is a seasonal contagious respiratory disease caused by influenza viruses; it presents with high fever, muscle pain, and severe fatigue.

COVID-19

Enfeksiyon Hastalıkları

COVID-19 is a contagious disease caused by the SARS-CoV-2 coronavirus with a wide clinical spectrum ranging from asymptomatic to severe pneumonia.

Upper Respiratory Tract Infection

Enfeksiyon Hastalıkları

Upper respiratory tract infections are diseases that include common cold, pharyngitis, sinusitis, and laryngitis, often of viral origin and self-limited.

Urinary Tract Infection

Enfeksiyon Hastalıkları

Urinary tract infections are common bacterial infections most often caused by Escherichia coli, presenting with burning and frequent urination.

Hepatitis A (HAV)

Enfeksiyon Hastalıkları

Hepatitis A is an acute, self-limited liver infection transmitted via the fecal-oral route causing acute hepatitis without chronicity; supportive care suffices in most cases, while vaccination prevents outbreaks and post-exposure prophylaxis within 2 weeks is effective.

Hepatitis B

Enfeksiyon Hastalıkları

Hepatitis B is a contagious infection caused by HBV virus transmitted via blood, sexual intercourse, and mother-to-child, that can become chronic and progress to cirrhosis and liver cancer.

Hepatitis C

Enfeksiyon Hastalıkları

Hepatitis C is a liver disease caused by HCV virus transmitted mainly by blood; the rate of chronicity is high, but cure is possible with new antiviral drugs.

HIV/AIDS Information

Enfeksiyon Hastalıkları

HIV is a virus that targets the immune system; if untreated, it progresses to AIDS. With modern antiretroviral therapy, HIV-positive individuals can lead healthy, long lives.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.